MONDELEZ INTERNATIONAL INC Common Stock (MDLZ-Q)

Limited private-label competition. During pandemic, good at passing cost increases along to consumers without demand falling off. Concerns about impact of weight-loss drugs has abated. But huge increase in cocoa prices, at 47-year highs. Still happy to own.

It is a large consumer products company and has gone though re-structuring. Pays a rock solid dividend. Although high quality it is low growth so he sees better better value in the field.

International snack giant. 200-day MA is sideways to slightly negative, stock price is now below it. Fundamentals show only mid-single-digit earnings growth, paying 20x for it. Cost pressures, margin compression. Intense competition. Foreign currency has not helped.

For a consumer staples name, look at Loblaw or COST.

Owns shares and would recommend buying. Global consumer goods powerhouse. Strong brand names with sticky adoption rates. Ability to generate profits despite higher chocolate prices. Would recommend holding for the long term. Ability to pass on rising costs to consumers. 

Still likes it. Concern now is that with higher interest rates and rising unemployment, consumers are being more price-conscious. Company has acknowledged this in its biscuit category. 

Reassessing pricing and packaging. EMs are about 40% of sales, she sees higher growth there. Selling assets, redeploying proceeds in higher-growth adjacent categories.

Nothing much has changed in MDLZ’s fundamentals over the years, except the valuation has gone down and it is now trading at 18.8x times' Forward P/E ( a fair valuation given MDLZ consistently has traded above 20x). The leverage level has gone down meaningfully in recent years, and the net debt/EBITDA level is now at 1.9x, the lowest in years, indicating a capacity for raising dividends or buying back shares. The company has been a predictable grower, and we think MDLZ would be comfortable to grow 3%-5% for a very long time, it is an attractive dividend grower over time, but the business is mature and fairly low growth overall. We would be OK owning it for income but otherwise do not see it as overly interesting. 
Unlock Premium - Try 5i Free

Good company, but now up against weight-loss drugs. Makes the core thesis tough. High cocoa prices increased input prices. Lots of international sales, so a strong USD is not constructive.

At the time of this pick, GLP weight-loss drugs were creating overhang on the stock. Very well run. Great presence internationally. Recent quarter underwhelming, lower-income US consumer starting to get pressured. Happy to hold due to market dominance and attractive valuation.

A leader in biscuits and chocolate, with very little private label competition. Very strong brand loyalty. Innovating and acquiring. Disposing of lower-growth areas such as gum. Likes the topline growth, as well as incremental margin growth. Decent yield of 2.4%.

Return on capital inconsistent and low. Free cash flow also not too high. Insider ownership also unclear. Food and beverage hard to compete with if company has a strong moat. Unclear on future of business. Better options for investors in the markets. 

Owns shares and believes in prospects of business. Chocolate business very strong. "Snack business" also growing at high rate. Able to pass on costs to consumers. Brand loyalty continues to grown. Strong array of products. Stable business that is good for defensive investors. 

Owns a lot of products that don't make money, no return on capital, so needs to rationalize its products. Own these companies now, because you'll reap from the fruition of these efforts. May be some volatility.

Have pricing power, passing higher prices to consumers. Are rapidly growing in emerging markets like Africa. It yields 2.4% now and grows its dividend at 13% compounded over the last decade. It's highly defensive, boasting strong brands like Cadbury.

Very strong portfolio of brands (Oreo & Ritz etc.). Recent selloff of stock due to weight loss drugs hitting the market. Not worried about selloff and believes is over stated. Very attractive share price to buy at. 

It pulled back due to a new obesity drug with concerns that this may reduce consumption of their products which are mainly snacks - it leads in biscuits and chocolate. However there is lots of brand loyalty and it is branching out into different categories. There is long term growth with 35% of its revenue coming from emerging  markets. It is at a good entry point.